356 results on '"Mirimanoff, René-Olivier"'
Search Results
2. Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01)
3. Fractionated Irradiation Combined with Carbogen Breathing and Nicotinamide of Two Human Glioblastomas Grafted in Nude Mice
4. Effect of Pentoxifylline on Radiation-Induced ${\rm G}_{2}\text{-}\text{Phase}$ Delay and Radiosensitivity of Human Colon and Cervical Cancer Cells
5. Electron Therapy of Skin Carcinomas
6. ESTRO-ACROP guideline “target delineation of glioblastomas”
7. Data from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
8. Supplementary Figure 4 from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
9. Supplementary Figure 7 from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
10. Supplementary Figure Legend from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
11. Supplementary Figure 1 from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
12. Supplementary Figure 8 from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
13. Supplementary Figure 2 from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
14. Supplementary Figure 5 from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
15. Supplementary Figure 6 from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
16. Supplementary Figure 3 from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
17. Supplementary Table 1 from CYR61 and αVβ5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
18. Data from CYR61 and αVβ5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
19. Supplementary Figure 1 from CYR61 and αVβ5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
20. Supplementary Figure 2 from CYR61 and αVβ5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
21. Supplementary Methods and Materials from CYR61 and αVβ5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
22. Supplementary Figure 3 from CYR61 and αVβ5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
23. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
24. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
25. Skull Base Tumors: Fractionated Stereotactic Radiotherapy Perspective
26. Les esthésioneuroblastomes
27. 3D dose reconstruction for narrow beams using ion chamber array measurements
28. EORTC topics in neurooncology: The long path from a focus on neurological complications of cancer towards molecularly defined trials and therapies in neurooncology
29. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial
30. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
31. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial
32. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
33. Physical considerations on discrepancies in target volume delineation
34. Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial
35. Electron Therapy of Skin Carcinomas
36. Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial
37. European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey
38. The Reasons for Discrepancies in Target Volume Delineation: A SASRO Study on Head-and-Neck and Prostate Cancers
39. The evolution of chemoradiation for glioblastoma: A modern success story
40. Decreased Local Control Following Radiation Therapy Alone in Early-Stage Glottic Carcinoma with Anterior Commissure Extension*
41. Dexamethasone-Induced Enhancement of Resistance to Ionizing Radiation and Chemotherapeutic Agents in Human Tumor Cells
42. Concurrent Chemoradiotherapy for Malignant Glioma: Dead End or Highway?
43. Isolated Limb Perfusion With Tumor Necrosis Factor and Melphalan for Non-Resectable Soft Tissue Sarcomas: Long-Term Results on Efficacy and Limb Salvage in a Selected Group of Patients
44. Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial
45. Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review
46. Fetal dose reduction in head and neck radiotherapy of a pregnant woman
47. Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma
48. Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy
49. The Reasons for Discrepancies in TargetVolume Delineation: A SASRO Study on Head-and-Neck and Prostate Cancers
50. Prostate cancer: On the road of progress
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.